Review Article
Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer
Table 1
Drugs targeted to decrease ROS.
| Drugs | Targeted strategy | Mechanism | Reference |
| N-Acetyl-L-cysteine | Antioxidant agent | Scavenging ROS to inhibit proliferation and invasion | [53] |
| Anti-Duox2 monoclonal antibody | Nox suppressor | Neutralizing Nox isoenzyme to decrease ROS production | [54] |
| Longikaurin E | ROS-related pathway blocker | Inhibiting p38-MAPK and PI3K/Akt pathway to induce apoptosis | [55] |
| Nexrutine | ROS-related pathway blocker | Inhibiting STAT3/LC3/ROS | [56] |
| ACEI | Stromal cell inactivator | Decreasing ROS in PSC to inhibit pancreatic fibrosis | [57] |
| α-Mangostin | Stromal cell inactivator | Inhibiting ROS-induced PSC activation to attenuate pancreatic cancer cell invasion | [31] |
|
|